Israel’s Biocancell Therapeutics Ltd has reported success in the Phase IIb clinical trial of BC-819 for the treatment of bladder cancer in patients for whom chemotherapy or standard treatment using Bacillus Calmette-Guerin (BCG) failed.
http://www.globes.co.il/serveen/globes/docview.asp?did=1000830282